Table 2 Baseline Characteristics of the Treated HCV Group

N

109

74

Male(%)

79 (72.5%)

51 (68.9%)

Mean age (years)

48.4 ± 7.82

51.8 ± 7.41

BMI

23.7 ± 2.72

23.7 ± 3.02

HCV load (Log₁₀)

5.64 ± 1.01

6.35 ± 0.76

 1b

50 (45.9%)

61 (82.4%)

 2a

56 (51.4%)

13 (17.6%)

 Unclassified

3 (2.7%)

–

FBG (mmol/l)

5.14 ± 0.81

5.52 ± 0.83

FCP (nmol/l)

0.92 ± 0.25

0.95 ± 0.33

FINS (μU/ml)

8.30 ± 3.80

9.08 ± 4.88

HOMA-IR

2.00 ± 1.02

2.27 ± 1.37

HOMA-β

104.5 ± 71.92

104.5 ± 77.53

ISI

−3.70 ± 0.45

−3.77 ± 0.56

ALT (U/L)

64.0 (34.3, 131.5)

49.6 (30.7, 72.6)

AST (U/L)

49.4 (32.2, 75.5)

39.9 (30.5, 62.6)

ALP (U/L)

85.0 (70.5, 113.5)

86.0 (64.8, 106.5)

GGT (U/L)

45.0 (25.3, 90.8)

44.0 (23.3, 86.3)

ALB (g/l)

48.2 (44.7, 52.5)

46.9 (43.9, 50.0)

TBIL (μmol/l)

17.8 (12.9, 28.2)

15.9 (11.3, 23.0)

CHE (U/L)

7598 (6721, 8030)

7835 (6870, 8148)